Massachusetts General Hospital in Boston has spun off a gene-editing diagnostics company aiming to partner with pharma companies to create new therapies that use the technology.
Read the full post on Becker's Hospital Review - Healthcare News
Gene-editing spinoff led by Mass General Brigham veterans
